These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24713731)

  • 1. Pathology consultation on electronic crossmatch.
    Mazepa MA; Raval JS; Park YA;
    Am J Clin Pathol; 2014 May; 141(5):618-24. PubMed ID: 24713731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic crossmatching.
    Arslan O
    Transfus Med Rev; 2006 Jan; 20(1):75-9. PubMed ID: 16373190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of the immediate spin crossmatch when used for detecting ABO incompatibility.
    Berry-Dortch S; Woodside CH; Boral LI
    Transfusion; 1985; 25(2):176-8. PubMed ID: 3984013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the crossmatch in testing for serologic incompatibility.
    Oberman HA; Barnes BA; Steiner EA
    Transfusion; 1982; 22(1):12-6. PubMed ID: 6801826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety in transfusion practice. Is it safe to eliminate the major crossmatch for selected patients?
    Shulman IA; Kent D
    Arch Pathol Lab Med; 1989 Mar; 113(3):270-2. PubMed ID: 2919957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with the routine use of an abbreviated crossmatch.
    Shulman IA; Nelson JM; Saxena S; Thompson JC; Okamoto M; Kent DR; Nakayama RK
    Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for the electronic crossmatch.
    Judd WJ
    Vox Sang; 1998; 74 Suppl 2():409-17. PubMed ID: 9704475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 11. Electronic verification of donor-recipient compatibility: the computer crossmatch.
    Butch SH; Judd WJ; Steiner EA; Stoe M; Oberman HA
    Transfusion; 1994 Feb; 34(2):105-9. PubMed ID: 8310478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The gel centrifugation test in serologic compatibility testing].
    Hitzler W; Bauernfeind U; Schömig-Brekner J; Mathias D
    Beitr Infusionsther; 1990; 26():358-61. PubMed ID: 1703871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
    Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
    East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch.
    Padmore R; Berardi P; Erickson K; Desjardins D; Giulivi A; Tokessy M; Neurath D; Saidenberg E
    Transfus Apher Sci; 2014 Oct; 51(2):168-71. PubMed ID: 25175412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
    Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
    Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of therapeutic antibodies used in desensitization protocols on lymphocytotoxicity crossmatch results.
    Milongo D; Vieu G; Blavy S; Del Bello A; Sallusto F; Rostaing L; Kamar N; Congy-Jolivet N
    Transpl Immunol; 2015 Jun; 32(3):151-5. PubMed ID: 25936347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.